CTN Webinar: Identifying, Reporting, and Resolving Adverse Events in CTN Trials.
CTN Webinar: Identifying, Reporting, and Resolving Adverse Events in CTN Trials. – This one-hour webinar, produced by the National Drug Abuse Treatment Clinical Trials Network (CTN) Clinical Coordinating Center for CTN members and the public, provides guidelines on methods that have improved adverse event and serious adverse event identification and reporting in behavioral trials. The webinar includes discussion of the clinical and regulatory importance of monitoring safety in research studies; process recommendations for identifying, reviewing, reporting, and resolving safety events; and information about who is resonsible for what, and what resources are available to facilitate the process. The target audience includes novice and experienced CTN or other research staff working in community treatment programs in the substance abuse field. Presented by Blake Apple (University of Texas Southwestern Medical Center, TX Node), Maria Campanella, RN, BSN (EMMES Corporation), and Robert Lindblad, MD (EMMES Corporation). For more resources related to this webinar, as well as other webinars in this series, visit: ctndisseminationlibrary.org
Major League Baseball, Players' Union agree to expand HGH, PEDs testing
Filed under: drug treatment programs in maryland
MLB and the player's union jointly agreed upon the decision to modify their collectively-bargained Joint Drug Prevention and Treatment Program. Commissioner Bud Selig announced the additions yesterday at the owners' meetings in Paradise … Elijah …
Read more on The Star-Ledger – NJ.com
Distributing Naloxone to Heroin Users Highly Cost Effective
Filed under: drug treatment programs in maryland
In a second analysis, naloxone distribution would prevent 6.1% of overdose deaths; in that analysis, the number needed to treat to prevent 1 overdose death was 227. … In an accompanying commentary, Wilson Compton, MD, National Institute on Drug Abuse …
Read more on Medscape